Secreted protein kinases

Trends in Biochemical Sciences

Volumn 38, Issue 3, 2013, Pages 121-130

  Tagliabracci, Vincent S ^a   Pinna, Lorenzo A ^b   Dixon, Jack E ^a,c,d  

^a University of California San Diego   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN; CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; PROTEIN FAM20A; PROTEIN FAM20B; PROTEIN FAM20C; PROTEIN KINASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BINDING AFFINITY; BIOMINERALIZATION; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL MOTILITY; CELL SURVIVAL; ENDOPLASMIC RETICULUM; EXOPHTHALMOS; GENE DELETION; GENE DUPLICATION; GLYCOGENOLYSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MORPHOGENESIS; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; STOICHIOMETRY;

ANIMALS; HUMANS; PROTEIN KINASES;

EID: 84874244868     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2012.11.008     Document Type: Review

References (96)

1. Hammarsten O. Zur Frage ob Caseín ein einheitlicher Stoff sei. Hoppe-Seyler's Z. Physiol. Chem. 1883, 227-273.
2. Tagliabracci V.S., et al. Secreted kinase phosphorylates extracellular proteins that regulate biomineralization. Science 2012, 336:1150-1153.
3. Lipmann F. über die Bindung der Phosphorsäre in Phosphorproteinen. I. Biochem. Z 1933, 262:3.
4. Lipmann F.A., Levene P.A. Serine phosphoric acid obtained on hydrolysis of vitellinic acid. J. Biol. Chem. 1932, 98:109-114.
5. Burnett G., Kennedy E.P. The enzymatic phosphorylation of proteins. J. Biol. Chem. 1954, 211:969-980.
6. Krebs E.G., Fischer E.H. The phosphorylase b to a converting enzyme of rabbit skeletal muscle. Biochim. Biophys. Acta 1956, 20:150-157.
7. Rabinowitz M., Lipmann F. Reversible phosphate transfer between yolk phosphoprotein and adenosine triphosphate. J. Biol. Chem. 1960, 235:1043-1050.
8. Walsh D.A., et al. An adenosine 3',5'-monophosphate-dependent protein kinase from rabbit skeletal muscle. J. Biol. Chem. 1968, 243:3763-3765.
9. Pinna L.A., et al. Isolation and properties of a protein kinase from rat liver microsomes. Biochim. Biophys. Acta 1969, 178:199-201.
10. Rodnight R., Lavin B.E. Phosvitin kinase from brain: activation by ions and subcellular distribution. Biochem. J. 1964, 93:84-91.
11. Allende J.E., Allende C.C. Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation. FASEB J. 1995, 9:313-323.
12. Bingham E.W., et al. Phosphorylation of casein. Role of the Golgi apparatus. J. Biol. Chem. 1972, 247:8193-8194.
13. Moore A., et al. Purification and tissue-specific expression of casein kinase from the lactating guinea-pig mammary gland. Eur. J. Biochem. 1985, 152:729-737.
14. Mercier J.C. Phosphorylation of caseins, present evidence for an amino acid triplet code posttranslationally recognized by specific kinases. Biochimie 1981, 63:1-17.
15. Mercier J.C., et al. [Primary structure of bovine s1 casein. Complete sequence]. Eur. J. Biochem. 1971, 23:41-51.
16. Lasa-Benito M., et al. Golgi apparatus mammary gland casein kinase: monitoring by a specific peptide substrate and definition of specificity determinants. FEBS Lett. 1996, 382:149-152.
17. Meggio F., et al. Synthetic fragments of beta-casein as model substrates for liver and mammary gland casein kinases. Eur. J. Biochem. 1989, 186:459-464.
18. Meggio F., et al. Substrate-specificity determinants for a membrane-bound casein kinase of lactating mammary gland. A study with synthetic peptides. Eur. J. Biochem. 1988, 177:281-284.
19. Lasa M., et al. Rat liver Golgi apparatus contains a protein kinase similar to the casein kinase of lactating mammary gland. Eur. J. Biochem. 1997, 243:719-725.
20. Duncan J.S., et al. Purification of Golgi casein kinase from bovine milk. Biochem. J. 2000, 350:463-468.
21. Pouliot Y., Karp P.D. A survey of orphan enzyme activities. BMC Bioinformatics 2007, 8:244.
22. Ishikawa H.O., et al. Four-jointed is a Golgi kinase that phosphorylates a subset of cadherin domains. Science 2008, 321:401-404.
23. Barylko B., et al. A novel family of phosphatidylinositol 4-kinases conserved from yeast to humans. J. Biol. Chem. 2001, 276:7705-7708.
24. Correia F.F., et al. Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J. Bacteriol. 2006, 188:8360-8367.
25. Ishikawa H.O., et al. The Raine syndrome protein FAM20C is a Golgi kinase that phosphorylates bio-mineralization proteins. PLoS ONE 2012, 7:e42988.
26. Lolli G., et al. Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight. Biochemistry 2012, 51:6097-6107.
27. Manning G., et al. The protein kinase complement of the human genome. Science 2002, 298:1912-1934.
28. Yang C.H., et al. Regulation of Frizzled by fat-like cadherins during planar polarity signaling in the Drosophila compound eye. Cell 2002, 108:675-688.
29. Zhao B., et al. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 2010, 24:862-874.
30. Cho E., et al. Delineation of a Fat tumor suppressor pathway. Nat. Genet. 2006, 38:1142-1150.
31. Rock R., et al. Fjx1: a notch-inducible secreted ligand with specific binding sites in developing mouse embryos and adult brain. Dev. Dyn. 2005, 234:602-612.
32. Bendtsen J.D., et al. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 2004, 340:783-795.
33. Ashery-Padan R., et al. Fjx1, the murine homologue of the Drosophila four-jointed gene, codes for a putative secreted protein expressed in restricted domains of the developing and adult brain. Mech. Dev. 1999, 80:213-217.
34. Probst B., et al. The rodent Four-jointed ortholog Fjx1 regulates dendrite extension. Dev. Biol. 2007, 312:461-470.
35. Nalbant D., et al. FAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells. BMC Genomics 2005, 6:11.
36. Vogel P., et al. Amelogenesis imperfecta and other biomineralization defects in Fam20a and Fam20c null mice. Vet. Pathol. 2012, 49:998-1017.
37. O'Sullivan J., et al. Whole-exome sequencing identifies FAM20A mutations as a cause of amelogenesis imperfecta and gingival hyperplasia syndrome. Am. J. Hum. Genet. 2011, 88:616-620.
38. Cho S.H., et al. Novel FAM20A mutations in hypoplastic amelogenesis imperfecta. Hum. Mutat. 2012, 33:91-94.
39. Backman B., Holm A.K. Amelogenesis imperfecta: prevalence and incidence in a northern Swedish county. Community Dent. Oral Epidemiol. 1986, 14:43-47.
40. Eastoe J.E. Organic matrix of tooth enamel. Nature 1960, 187:411-412.
41. Stephanopoulos G., et al. Genes and related proteins involved in amelogenesis imperfecta. J. Dent. Res. 2005, 84:1117-1126.
42. Koike T., et al. FAM20B is a kinase that phosphorylates xylose in the glycosaminoglycan-protein linkage region. Biochem. J. 2009, 421:157-162.
43. Bishop J.R., et al. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007, 446:1030-1037.
44. Gulberti S., et al. Phosphorylation and sulfation of oligosaccharide substrates critically influence the activity of human beta1,4-galactosyltransferase 7 (GalT-I) and beta1,3-glucuronosyltransferase I (GlcAT-I) involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans. J. Biol. Chem. 2005, 280:1417-1425.
45. Tone Y., et al. 2-o-Phosphorylation of xylose and 6-o-sulfation of galactose in the protein linkage region of glycosaminoglycans influence the glucuronyltransferase-I activity involved in the linkage region synthesis. J. Biol. Chem. 2008, 283:16801-16807.
46. Eames B.F., et al. Mutations in fam20b and xylt1 reveal that cartilage matrix controls timing of endochondral ossification by inhibiting chondrocyte maturation. PLoS Genet. 2011, 7:e1002246.
47. Wang X., et al. Expression of FAM20C in the osteogenesis and odontogenesis of mouse. J. Histochem. Cytochem. 2010, 58:957-967.
48. Hao J., et al. Dentin matrix protein 4, a novel secretory calcium-binding protein that modulates odontoblast differentiation. J. Biol. Chem. 2007, 282:15357-15365.
49. Wang X., et al. Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice. PLoS Genet. 2012, 8:e1002708.
50. Raine J., et al. Unknown syndrome: microcephaly, hypoplastic nose, exophthalmos, gum hyperplasia, cleft palate, low set ears, and osteosclerosis. J. Med. Genet. 1989, 26:786-788.
51. Simpson M.A., et al. Mutations in FAM20C also identified in non-lethal osteosclerotic bone dysplasia. Clin. Genet. 2009, 75:271-276.
52. Fradin M., et al. Osteosclerotic bone dysplasia in siblings with a Fam20C mutation. Clin. Genet. 2011, 80:177-183.
53. Simpson M.A., et al. Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine syndrome), highlighting a crucial molecule in bone development. Am. J. Hum. Genet. 2007, 81:906-912.
54. Wang X., et al. FAM20C plays an essential role in the formation of murine teeth. J. Biol. Chem. 2012, 287:35934-35942.
55. Meszaros R., et al. Expression of the novel gene Ened during mouse and Xenopus embryonic development. Int. J. Dev. Biol. 2008, 52:1119-1122.
56. Salvi M., et al. Motif analysis of phosphosites discloses a potential prominent role of the Golgi casein kinase (GCK) in the generation of human plasma phospho-proteome. J. Proteome Res. 2010, 9:3335-3338.
57. Bahl J.M., et al. Characterization of the human cerebrospinal fluid phosphoproteome by titanium dioxide affinity chromatography and mass spectrometry. Anal. Chem. 2008, 80:6308-6316.
58. Zhou W., et al. An initial characterization of the serum phosphoproteome. J. Proteome Res. 2009, 8:5523-5531.
59. Lasa M., et al. Phosphorylation of osteopontin by Golgi apparatus casein kinase. Biochem. Biophys. Res. Commun. 1997, 240:602-605.
60. Kawasaki K. The SCPP gene family and the complexity of hard tissues in vertebrates. Cells Tissues Organs 2011, 194:108-112.
61. George A., Veis A. Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition. Chem. Rev. 2008, 108:4670-4693.
62. McMahon H.E., et al. Phosphorylation of bone morphogenetic protein-15 and growth and differentiation factor-9 plays a critical role in determining agonistic or antagonistic functions. Endocrinology 2008, 149:812-817.
63. Tibaldi E., et al. Golgi apparatus casein kinase phosphorylates bioactive Ser-6 of bone morphogenetic protein 15 and growth and differentiation factor 9. FEBS Lett. 2010, 584:801-805.
64. Dolcini L., et al. Identification of the amniotic fluid insulin-like growth factor binding protein-1 phosphorylation sites and propensity to proteolysis of the isoforms. FEBS J. 2009, 276:6033-6046.
65. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 1995, 16:3-34.
66. Atoda H., et al. Characterization of a monoclonal antibody B1 that recognizes phosphorylated Ser-158 in the activation peptide region of human coagulation factor IX. J. Biol. Chem. 2006, 281:9314-9320.
67. Farrell H.M., et al. The caseins of milk as calcium-binding proteins. Methods Mol. Biol. 2002, 172:97-140.
68. Chan H.C., et al. Altered enamelin phosphorylation site causes amelogenesis imperfecta. J. Dent. Res. 2010, 89:695-699.
69. Kwak S.Y., et al. Role of 20-kDa amelogenin (P148) phosphorylation in calcium phosphate formation in vitro. J. Biol. Chem. 2009, 284:18972-18979.
70. Levene P.A., Alsberg C. Zur chemie der paranucleinsaure. Hoppe-Seyler's Z. Physiol. Chem. 1900, 31:543-555.
71. Meggio F., Pinna L.A. Phosphorylation of phosvitin by casein kinase-2 provides the evidence that phosphoserines can replace carboxylic amino acids as specificity determinants. Biochim. Biophys. Acta 1988, 971:227-231.
72. Capasso J.M., et al. Mechanism of phosphorylation in the lumen of the Golgi apparatus. Translocation of adenosine 5'-triphosphate into Golgi vesicles from rat liver and mammary gland. J. Biol. Chem. 1989, 264:5233-5240.
73. Redegeld F.A., et al. Ecto-protein kinases: ecto-domain phosphorylation as a novel target for pharmacological manipulation?. Trends Pharmacol. Sci. 1999, 20:453-459.
74. Puglielli L., et al. Identification, purification, and characterization of the rat liver Golgi membrane ATP transporter. J. Biol. Chem. 1999, 274:12665-12669.
75. Maeda Y., et al. GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus. Nat. Cell Biol. 2008, 10:1135-1145.
76. Thompson R.J., et al. Anion channels transport ATP into the Golgi lumen. Am. J. Physiol. Cell Physiol. 2006, 290:C499-C514.
77. Caldwell J.H., Howell K.E. Pores galore for the Golgi. Nat. Cell Biol. 2008, 10:1125-1126.
78. +-ATPase. J. Biol. Chem. 2003, 278:33436-33444.
79. Drury A.N., Szent-Gyorgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J. Physiol. 1929, 68:213-237.
80. Corriden R., Insel P.A. Basal release of ATP: an autocrine-paracrine mechanism for cell regulation. Sci. Signal. 2010, 3:re1.
81. May L.T., Sehgal P.B. Phosphorylation of interleukin-6 at serine 54: an early event in the secretory pathway in human fibroblasts. Biochem. Biophys. Res. Commun. 1992, 185:524-530.
82. Dewpura T., et al. PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo and circulates as a phosphoprotein in humans. FEBS J. 2008, 275:3480-3493.
83. Tang J., et al. Amino-acid sequence of porcine pepsin. Proc. Natl. Acad. Sci. U.S.A. 1973, 70:3437-3439.
84. Blombaeck B., et al. Amino-acid sequence and the occurrence of phosphorus in human fibrinopeptides. Nature 1962, 193:833-834.
85. Dockray G.J., et al. Post-translational processing of the porcine gastrin precursor by phosphorylation of the COOH-terminal fragment. J. Biol. Chem. 1987, 262:8643-8647.
86. Lee S.N., et al. Neuroendocrine protein 7B2 can be inactivated by phosphorylation within the secretory pathway. J. Biol. Chem. 2006, 281:3312-3320.
87. Bennett H.P., et al. Biosynthesis of phosphorylated forms of corticotropin-related peptides. Proc. Natl. Acad. Sci. U.S.A. 1981, 78:4713-4717.
88. Giorgianni F., et al. Identification and characterization of phosphorylated proteins in the human pituitary. Proteomics 2004, 4:587-598.
89. Gadroy P., et al. Phosphorylation and O-glycosylation sites of human chromogranin A (CGA79-439) from urine of patients with carcinoid tumors. J. Biol. Chem. 1998, 273:34087-34097.
90. Beranova-Giorgianni S., et al. Phosphoproteomic analysis of the human pituitary. Pituitary 2006, 9:109-120.
91. Strub J.M., et al. Phosphorylation and O-glycosylation sites of bovine chromogranin A from adrenal medullary chromaffin granules and their relationship with biological activities. J. Biol. Chem. 1997, 272:11928-11936.
92. Watkinson A., et al. The isolation and chemical characterization of phosphorylated enkephalin-containing peptides from bovine adrenal medulla. J. Biol. Chem. 1989, 264:3061-3065.
93. Colaert N., et al. Improved visualization of protein consensus sequences by iceLogo. Nat. Methods 2009, 6:786-787.
94. Salvi M., et al. Variable contribution of protein kinases to the generation of the human phosphoproteome: a global weblogo analysis. Biomol. Concepts 2010, 1:185-195.
95. Roach P.J. Multisite and hierarchal protein phosphorylation. J. Biol. Chem. 1991, 266:14139-14142.
96. Brunati A.M., et al. Novel consensus sequence for the Golgi apparatus casein kinase, revealed using proline-rich protein-1 (PRP1)-derived peptide substrates. Biochem. J. 2000, 351:765-768.